Beta Drugs Ltd.
BSE: 535022 | Sector: Health care |
NSE: BETA | ISIN Code: INE351Y01019 |
BSE 05:30 | 01 Jan | Beta Drugs Ltd |
NSE 00:00 | 30 Jun | 709.35 |
5.60 (0.80%) |
OPEN
777.00 |
HIGH
777.00 |
LOW
709.00 |
OPEN | |
PREVIOUS CLOSE | |
VOLUME | |
52-Week high | 0.00 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 0 |
Buy Price | |
Buy Qty | |
Sell Price | |
Sell Qty |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Beta Drugs Ltd. (BETA) - Half Yearly Result
Particulars (![]() |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
Net Sales/Income From Operations | 65.32 | 59.53 | 44.64 | 34.82 | 31.09 |
Other Income | 0.35 | 0.51 | 0.34 | 0.27 | 0.29 |
Total Income | 65.67 | 60.04 | 44.98 | 35.09 | 31.38 |
Total Expenditure | 52.69 | 46.97 | 35.99 | 28.15 | 26.01 |
Operating Profit | 12.97 | 13.07 | 8.98 | 6.94 | 5.37 |
Interest | 0.20 | 0.21 | 0.38 | 0.39 | 0.41 |
Gross Profit | 12.77 | 12.86 | 8.61 | 6.54 | 4.96 |
Depreciation | 2.98 | 2.49 | 2.77 | 2.50 | 1.52 |
PBT | 9.80 | 10.37 | 5.84 | 4.04 | 3.44 |
Tax | 2.96 | 3.19 | 2.18 | 1.12 | 0.20 |
Net Profit/(Loss) | 6.91 | 7.34 | 3.92 | 3.06 | 3.09 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 6.91 | 7.34 | 3.92 | 3.06 | 3.09 |
Equity Share Capital | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 |
Reserves Excluding Revaluation Reserves | 67.85 | 61.14 | 53.80 | 49.89 | 46.83 |
EPS | |||||
Basic EPS | 7.18 | 7.64 | 4.07 | 3.18 | 3.26 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Beta Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices